Results 141 to 150 of about 901,705 (329)
The Domus Nozze D'Argento in Pompeii: Structural Diagnosis Using Geophysical Methods
Archaeological Prospection, EarlyView.ABSTRACT Monitoring of ancient buildings is an issue of great interest in view of a proper restoration. This paper describes the noninvasive monitoring of the Domus Nozze D'Argento in Pompeii. The Roman house, as occurred for many other buildings in Pompei, was buried in the ash from the 79 ad eruption of Mount Vesuvius.
Nicola Masini +4 more
wiley +1 more source
Arthritis &Rheumatology, EarlyView.Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi +6 more
wiley +1 more source
New Members of the Editorial Board and International Advisory Board of Angewandte Chemie [PDF]
, 2013 openalex +1 more source
Arthritis &Rheumatology, EarlyView.Objective The pharmacodynamic effects of litifilimab on type I interferon (IFN) response and correlations with clinical outcomes were investigated in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Methods Participants from part A (SLE) or part B (CLE with or without SLE) of the randomized phase 2 LILAC trial who received ...
Richard Furie +8 more
wiley +1 more source
Stefano Masi, recently appointed new EHJ International Editorial Board Member [PDF]
, 2020 Andros Tofield
openalex +1 more source
A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus
Arthritis &Rheumatology, Accepted Article.Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen +14 more
wiley +1 more source
Dr Jürgen H. Prochaska New EHJ International Editorial Board Member [PDF]
, 2020 Andros Tofield
openalex +1 more source
Arthritis &Rheumatology, Accepted Article.Objective Juvenile idiopathic arthritis (JIA) is associated with impaired overall health‐related quality of life (HRQoL). We evaluated the impact of tofacitinib on patient‐reported outcomes (PROs) in patients with JIA. Methods This was a post hoc analysis of a phase III, randomized, double‐blind, placebo‐controlled withdrawal trial (NCT02592434) in ...
Hermine I. Brunner +21 more
wiley +1 more source